v3.25.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Restricted Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed balance sheet (in thousands):

 

 

September 30, 2025

 

 

December 31, 2024

 

Cash and cash equivalents

 

$

37,931

 

 

$

28,670

 

Restricted cash, non-current

 

 

 

 

 

64

 

Total cash, cash equivalents and restricted cash

 

$

37,931

 

 

$

28,734

 

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed balance sheet (in thousands):

 

 

September 30, 2025

 

 

December 31, 2024

 

Cash and cash equivalents

 

$

37,931

 

 

$

28,670

 

Restricted cash, non-current

 

 

 

 

 

64

 

Total cash, cash equivalents and restricted cash

 

$

37,931

 

 

$

28,734

 

Schedule of Inventory

Details of inventory are presented as follows (in thousands):

 

 

September 30, 2025

 

 

December 31, 2024

 

Raw materials

 

$

 

 

$

3,533

 

Work in process

 

 

 

 

 

 

Finished goods

 

 

 

 

 

1,778

 

Total

 

$

 

 

$

5,311

 

 

Schedule of Property, Plant and Equipment

Details of property and equipment are presented as follows (in thousands):

 

 

September 30, 2025

 

 

December 31, 2024

 

Computers and Software

 

$

341

 

 

$

470

 

Construction in process

 

 

 

 

 

6,590

 

Furniture and fixtures

 

 

36

 

 

 

65

 

Lab equipment

 

 

 

 

 

51

 

Leasehold improvements

 

 

 

 

 

133

 

Total

 

$

377

 

 

$

7,309

 

Accumulated depreciation

 

 

(373

)

 

 

(463

)

Property and equipment, net

 

$

4

 

 

$

6,846

 

Schedule Of Gross-To-Net Sales Adjustments

The following table sets forth the changes in the accrued revenue allowances (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Balance at beginning of period

 

$

 

 

$

1,289

 

 

$

1,411

 

 

$

1,065

 

Provision for current period sales

 

 

 

 

 

1,710

 

 

 

2,085

 

 

 

4,695

 

Payments

 

 

 

 

 

(1,894

)

 

 

(1,686

)

 

 

(4,655

)

Allowances transferred in sale of Aadi Subsidiary, Inc.

 

 

 

 

 

 

 

 

(1,810

)

 

 

 

Balance at end of period

 

$

 

 

$

1,105

 

 

$

 

 

$

1,105

 

Schedule of Earnings Per Share, Basic and Diluted

The computations for basic and diluted EPS were as follows (in thousands, except shares and per share amounts):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net income (loss) for basic and diluted EPS

 

$

(17,746

)

 

$

(12,546

)

 

$

2,655

 

 

$

(45,418

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares for basic EPS

 

 

69,204,899

 

 

 

27,041,327

 

 

 

59,417,911

 

 

 

27,010,791

 

Effect of dilutive stock options

 

 

 

 

 

 

 

 

35,423

 

 

 

 

Effect of dilutive restricted stock units

 

 

 

 

 

 

 

 

604,538

 

 

 

 

Weighted-average shares for diluted EPS

 

 

69,204,899

 

 

 

27,041,327

 

 

 

60,057,872

 

 

 

27,010,791

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic EPS

 

$

(0.26

)

 

$

(0.46

)

 

$

0.04

 

 

$

(1.68

)

Diluted EPS

 

$

(0.26

)

 

$

(0.46

)

 

$

0.04

 

 

$

(1.68

)